Kakourou 1997.

Study characteristics
Methods	Study Design: prospective comparative study Study Duration: not reported Number of Participants: 16 Study Dates: 1989 to 1994
Participants	Setting: inpatient paediatric unit in Athens, Greece  Inclusion Criteria: children admitted to the department within 3 days from onset of rash who had a diagnosis of EMM based on the following criteria:  an erythematous papulovesicular or bullous skin eruption with at least 1 target lesion; ulcerative lesions involving at least 2 mucosal surfaces. Exclusion Criteria: not reported Baseline Data: Disease classification, number of participants with SJS: SJS‐TEN overlap: TEN All classified as EMM Intervention: Mean age, years (range): 6 (+/− 4)  Sex distribution, Males: Females, 7:3 Comparator:  Mean age, years (range): 6.6 (+/− 5.2) Sex distribution, Males: Females, 3:3 Data not reported: SCORTEN BSA at baseline Disease duration prior to treatment Baseline comorbidities
Interventions	Intervention:  Corticosteroids (bolus infusion of methylprednisolone (4 mg/kg/day) for 2 more days after the fever had subsided and no new lesions had developed) (n = 10) Comparator:  Supportive care only (n = 6)
Outcomes	Mortality
Funding source	None reported.
Declarations of interest	None declared.
Notes